[
    [
        {
            "time": "2020-05-12",
            "original_text": "健帆生物拟发行可转债募资10亿，扩建血液净化产品产能等",
            "features": {
                "keywords": [
                    "健帆生物",
                    "可转债",
                    "募资",
                    "10亿",
                    "血液净化",
                    "产能扩建"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "健帆生物拟发行可转债募资10亿，扩建血液净化产品产能等",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-12",
            "original_text": "健帆生物(300529.SZ)拟公开发行不超过10亿元可转债用于血液净化产品产能扩建项目等",
            "features": {
                "keywords": [
                    "健帆生物",
                    "300529.SZ",
                    "可转债",
                    "10亿",
                    "血液净化",
                    "产能扩建"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "健帆生物(300529.SZ)拟公开发行不超过10亿元可转债用于血液净化产品产能扩建项目等",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-05-12",
            "original_text": "健帆生物：拟公开发行可转债募资不超过10亿元",
            "features": {
                "keywords": [
                    "健帆生物",
                    "可转债",
                    "募资",
                    "10亿"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "健帆生物：拟公开发行可转债募资不超过10亿元",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]